🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
June 2026
›
Biotechnology Industry
Insider Buy/Sell Details for the Biotechnology Industry — June 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1527)
All (1527)
Buys (161)
Sells (1366)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Jun 1, 2026
Sale
Shares
1,606
Price
$548.26
Total Value
$880.51K
Shares Held After
21,956
% of Holdings
6.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Jun 1, 2026
Sale
Shares
1,354
Price
$547.11
Total Value
$740.79K
Shares Held After
23,562
% of Holdings
5.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Jun 1, 2026
Sale
Shares
2,520
Price
$546.23
Total Value
$1.38M
Shares Held After
24,916
% of Holdings
9.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
EDGEMOND JAMES
— CFO AND TREASURER
Jun 1, 2026
Sale
Shares
1,440
Price
$544.96
Total Value
$784.74K
Shares Held After
27,436
% of Holdings
5.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Orchestra BioMed Holdings, Inc.
(OBIO)
Hochman David P
— Director
Jun 1, 2026
Purchase
Shares
5,000
Price
$3.83
Total Value
$19.15K
Shares Held After
1,064,029
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Orchestra BioMed Holdings, Inc.
(OBIO)
Sherman Darren
— Director
Jun 1, 2026
Sale
Shares
15,000
Price
$3.87
Total Value
$58.05K
Shares Held After
1,184,327
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Syndax Pharmaceuticals Inc
(SNDX)
Goldan Keith A.
— Chief Financial Officer
Jun 1, 2026
Sale
Shares
1,177
Price
$18.99
Total Value
$22.35K
Shares Held After
139,252
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Syndax Pharmaceuticals Inc
(SNDX)
Metzger Michael A
— Director
Jun 1, 2026
Sale
Shares
6,847
Price
$18.99
Total Value
$130.02K
Shares Held After
484,843
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MAIA Biotechnology, Inc.
(MAIA)
Smith Stan
— Director
Jun 1, 2026
Purchase
Shares
75,000
Price
$1.34
Total Value
$100.20K
Shares Held After
1,519,178
% of Holdings
4.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MAIA Biotechnology, Inc.
(MAIA)
Vitoc Vlad
— Director
Jun 1, 2026
Purchase
Shares
72,700
Price
$1.39
Total Value
$100.89K
Shares Held After
976,121
% of Holdings
7.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MAIA Biotechnology, Inc.
(MAIA)
Gryaznov Sergei
— Chief Scientific Officer
Jun 1, 2026
Purchase
Shares
2,000
Price
$1.34
Total Value
$2.69K
Shares Held After
46,511
% of Holdings
4.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MediWound Ltd.
(MDWD)
Fox David Morton
— Director
Jun 1, 2026
Purchase
Shares
1,797
Price
$13.99
Total Value
$25.15K
Shares Held After
22,283
% of Holdings
8.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MediWound Ltd.
(MDWD)
Fox David Morton
— Director
Jun 1, 2026
Purchase
Shares
10
Price
$14.23
Total Value
$142.30
Shares Held After
20,486
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MediWound Ltd.
(MDWD)
Fox David Morton
— Director
Jun 1, 2026
Purchase
Shares
1,730
Price
$14.22
Total Value
$24.61K
Shares Held After
20,476
% of Holdings
8.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MADRIGAL PHARMACEUTICALS, INC.
(MDGL)
Soergel David
— Chief Medical Officer
Jun 1, 2026
Sale
Shares
1,042
Price
$495.74
Total Value
$516.56K
Shares Held After
10,033
% of Holdings
9.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alkermes plc.
(ALKS)
Hopkinson Craig C.
— EVP R&D, Chief Medical Officer
Jun 1, 2026
Sale
Shares
9,000
Price
$41.67
Total Value
$375.04K
Shares Held After
77,389
% of Holdings
10.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ultragenyx Pharmaceutical Inc.
(RARE)
Horn Howard
— Chief Financial Officer
Jun 1, 2026
Sale
Shares
4,653
Price
$23.77
Total Value
$110.60K
Shares Held After
105,689
% of Holdings
4.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Arcus Biosciences, Inc.
(RCUS)
Azoy Alexander
— Chief Accounting Officer
Jun 1, 2026
Sale
Shares
2,562
Price
$25.77
Total Value
$66.02K
Shares Held After
39,581
% of Holdings
6.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CYTOKINETICS INC
(CYTK)
PARSHALL B LYNNE
— Director
Jun 1, 2026
Sale
Shares
5,000
Price
$74.08
Total Value
$370.40K
Shares Held After
15,784
% of Holdings
24.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CYTOKINETICS INC
(CYTK)
Kaye Edward M. MD
— Director
Jun 1, 2026
Sale
Shares
2,933
Price
$76.09
Total Value
$223.17K
Shares Held After
10,283
% of Holdings
22.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CYTOKINETICS INC
(CYTK)
Callos Andrew
— EVP, Chief Commercial Officer
Jun 1, 2026
Sale
Shares
15,000
Price
$74.08
Total Value
$1.11M
Shares Held After
58,555
% of Holdings
20.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Contineum Therapeutics, Inc.
(CTNM)
Lorrain Daniel S.
— Chief Scientific Officer
Jun 1, 2026
Sale
Shares
4,170
Price
$13.16
Total Value
$54.86K
Shares Held After
139,372
% of Holdings
2.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Faeth Therapeutics, Inc.
(FTH)
Peyer James
— 10% Owner
Jun 1, 2026
Sale
Shares
476
Price
$21.14
Total Value
$10.06K
Shares Held After
130,142
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Faeth Therapeutics, Inc.
(FTH)
Peyer James
— 10% Owner
Jun 1, 2026
Sale
Shares
24,524
Price
$20.00
Total Value
$490.48K
Shares Held After
130,618
% of Holdings
15.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Faeth Therapeutics, Inc.
(FTH)
Cambrian BioPharma Inc
— 10% Owner
Jun 1, 2026
Sale
Shares
476
Price
$21.14
Total Value
$10.06K
Shares Held After
130,142
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Faeth Therapeutics, Inc.
(FTH)
Cambrian BioPharma Inc
— 10% Owner
Jun 1, 2026
Sale
Shares
24,524
Price
$20.00
Total Value
$490.48K
Shares Held After
130,618
% of Holdings
15.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 1051–1100 of 1527 transactions (page 22 of 31)
Version: v26.7.3